Open-Label Extension Data of Repinatrabit for Patients With Phenylketonuria by Madaline Spencer| Published on: Apr 23, 2026

Open-Label Extension Data of Repinatrabit for Patients With Phenylketonuria by Madaline Spencer| Published on: Apr 23, 2026 Fernanda Leal-Pardinas, MD, MSc, Global Clinical Development Lead, Rare & Metabolic Disorders at Otsuka Pharmaceutical, discusses the open-label extension data from their study testing repinatrabit for patients with phenylketonuria (PKU). https://checkrare.com/open-label-extension-data-of-repinatrabit-for-patients-with-phenylketonuria/